These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 27469000)
1. Analysis of Mechanism-Based Inhibition of CYP 3A4 by a Series of Fluoroquinolone Antibacterial Agents. Watanabe A; Takakusa H; Kimura T; Inoue S; Kusuhara H; Ando O Drug Metab Dispos; 2016 Oct; 44(10):1608-16. PubMed ID: 27469000 [TBL] [Abstract][Full Text] [Related]
2. Difference in Mechanism-Based Inhibition of Cytochrome P450 3A4 and 3A5 by a Series of Fluoroquinolone Antibacterial Agents. Watanabe A; Takakusa H; Kimura T; Inoue SI; Kusuhara H; Ando O Drug Metab Dispos; 2017 Mar; 45(3):336-341. PubMed ID: 27974381 [TBL] [Abstract][Full Text] [Related]
3. Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib. Takakusa H; Wahlin MD; Zhao C; Hanson KL; New LS; Chan EC; Nelson SD Drug Metab Dispos; 2011 Jun; 39(6):1022-30. PubMed ID: 21363997 [TBL] [Abstract][Full Text] [Related]
4. Metabolism-dependent inhibition of CYP3A4 by lapatinib: evidence for formation of a metabolic intermediate complex with a nitroso/oxime metabolite formed via a nitrone intermediate. Barbara JE; Kazmi F; Parkinson A; Buckley DB Drug Metab Dispos; 2013 May; 41(5):1012-22. PubMed ID: 23404373 [TBL] [Abstract][Full Text] [Related]